Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Other Routine +

Nevis Brands Inc. Announces Expansion into the Functional Wellness Market with the Launch of OOMRA Adaptogen and Nootropic Beverages

Diversification into Non-THC Wellness Amidst Regulatory Overhang and Price Erosion

Executive Summary
  • Product Launch: Nevis Brands Inc. announced the launch of OOMRA™, a line of non-psychoactive adaptogen beverages (CLARITY and UNWIND formulations).
  • Strategic Pivot: The move diversifies revenue streams away from cannabis/hemp-derived THC products into the mainstream functional wellness market.
  • Revenue Timeline: Management expects OOMRA to begin contributing to revenues in Q3 2026.
  • Distribution: Currently Direct-to-Consumer (DTC) with discussions ongoing for convenience store placement.
  • Context: This follows a fiscal year where the company achieved positive operating cash flow ($62,102) and narrowed its operational loss to near break-even levels ($18,716 adjusted).
Material Impact
  • Market Reaction Divergence: Despite previous positive earnings in March 2026 (positive operating cash flow), the stock price has declined from $0.09 in October 2025 to $0.03 in May 2026. This indicates skepticism regarding the sustainability of growth or regulatory risks outweighing operational improvements.
  • Regulatory Risk Mitigation: The Dec 2025 news highlighted a federal government announcement ending the sale of Hemp Derived THC in late 2026. OOMRA is non-psychoactive, which mitigates this specific risk, but it does not eliminate the core business exposure immediately as revenue contribution starts Q3 2026.
  • Incremental Growth: The launch is consistent with previous expansion strategies (Major in NM/AZ, Happy Apple in Ohio). It lacks the "unexpected" nature required for a Material - Positive rating given the market's prior rejection of positive earnings news.
  • Capital Efficiency: While operating cash flow turned positive ($62k), scaling OOMRA will likely require additional capital or reinvestment, potentially straining liquidity before Q3 revenue materializes.
NEVI · Price
Company Overview
  • Core Business: Manufacturer and distributor of cannabis-infused beverages (Major™) and hemp-derived THC beverages (Happy Apple™).
  • Flagship Project: Major™ brand has sold over 5 million bottles since 2019 launch in Washington State.
  • Expansion Strategy: Multi-state growth into Illinois, New Mexico, Arizona, Ohio, New Jersey, Missouri, Wisconsin, and the Carolinas.
  • New Initiative: OOMRA™ functional wellness beverages (Adaptogens/Nootropics) designed to be alcohol-free and caffeine-free.
Read the original news release →

More from Nevis Brands Inc.